Updated Data on Gilteritinib in AML

Updated Data on Gilteritinib in AML
Don Photo

Don
3 Jahre 48 Ansichten
Kategorie:
Beschreibung:
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on the importance of the updated data on gilteritinib in acute myeloid leukemia (AML).